Sanofi Ventures
Michael Fleming is a Principal Scientist at Sanofi since June 2021, with a prior role as Scientist II and Scientist I at Editas Medicine from August 2019 to May 2021. Previously, Michael served as a Postdoctoral Scholar at the Novartis Institutes for BioMedical Research from October 2016 to August 2019 and completed a PhD in Neuroscience at the University of Pennsylvania from 2010 to 2016. Research expertise includes investigation of receptor tyrosine kinase signaling in somatosensory neuron development, resulting in multiple first-author publications and international conference presentations. Michael's experience includes managing multi-institutional research projects, supervising undergraduate students, and performing lab management duties during a research technician position at the University of Virginia. Michael holds a Bachelor’s Degree in Neuroscience from the University of Virginia, earned between 2005 and 2008.
This person is not in the org chart
This person is not in any offices
Sanofi Ventures
20 followers
Sanofi Ventures is the corporate venture capital arm of Sanofi. They have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health solutions.